Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review

Badr Alnasser

doi:doi:10.11648/j.hep.20220703.15

| Peer-Reviewed

Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review

Badr Alnasser

Published in International Journal of Health Economics and Policy (Volume 7, Issue 3)

Received: 25 August 2022 Accepted: 7 September 2022 Published: 16 September 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Diabetic patients require expensive long-term therapy and care and the all-embracing implication of such disease negatively impacts society as a whole. Multiple indicators show that large number of diabetes mellitus-affected countries are located in the Middle East, which in some estimates reach around sixty percent of the global diabetes pandemic. It is already acknowledged that the incessant expansion of a non-transmittable illness in this region forces huge monetary expenses on families and nations. This systematic review analyzed the literature on the economic cost of diabetes in the Middle East and yielded 13 studies focusing on this issue. Results show that Middle-Eastern countries bare substantial economic cost, directly and indirectly, for treating and managing its diabetes population. From those nations, the Arabic-speaking countries share a higher portion of diabetes cost compared to other countries. While the Gulf states comprised the highest proportion of such cost. Although studies have been conducted on the cost of diabetes mellitus in the Middle East, yet very little has had significant impact on the awareness of the economic problem associated with it. The focus of this study shall be to encapsulate existing evidence on the expense of diabetes mellitus in the Middle East, survey the strategies used to work out costs, and explore regions for future implication.

Published in	International Journal of Health Economics and Policy (Volume 7, Issue 3)
DOI	10.11648/j.hep.20220703.15
Page(s)	71-77
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Economic Cost, Diabetes, Middle East

References

[1]	Lin, X., Xu, Y., Pan, X. et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep [Internet]. 2020 [cited 2022 Jul 07]; 10 (14790). Available from: https://doi.org/10.1038/s41598-020-71908-9.
[2]	What is diabetes? [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2022 [cited 2022 Jul 08]. Available from: https://www.cdc.gov/diabetes/basics/diabetes.html.
[3]	Abuyassin B, Laher I. Diabetes epidemic sweeping the Arab world. World J Diabetes [Internet]. 2016 Apr 25 [cited 2022 Jul 08]; 7 (8): 165-74. Available from: doi: 10.4239/wjd.v7.i8.165. PMID: 27114755; PMCID: PMC4835661.
[4]	American Diabetes Association. Diabetes In General [Internet]. American Diabetes Association; 2022 [cited 2022 Jul 08]. Available from: https://diabetes.org/.
[5]	Medical News Today. The Signs of Uncontrolled Diabetes [Internet]. Brighton: Medical News Today; 2019 Apr 16 [cited 2022 Jul 10]. Available from: https://www.medicalnewstoday.com/articles/317465.
[6]	IDF Diabetes Atlas. Diabetes around the world 2021 [Internet]. IDF Diabetes Atlas; 2022 [cited 2022 Jul 10]. Available from: https://diabetesatlas.org/.
[7]	Schäfer-Graf UM, Gembruch U, Kainer F, Groten T, Hummel S, Hösli I, Grieshop M, Kaltheuner M, Bührer C, Kautzky-Willer A, Laubner K, Bancher-Todesca D. Gestational Diabetes Mellitus (GDM) - Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018). Geburtshilfe Frauenheilkd [Internet]. 2018 Dec [cited 2022 Jul 10]; 78 (12): 1219-1231. Available from: doi: 10.1055/a-0659-2596. Epub 2018 Dec 14. PMID: 30651660; PMCID: PMC6301211.
[8]	El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action. World J Diabetes [Internet]. 2021 Sep 15 [cited 2022 Aug 02]; 12 (9): 1401-1425. Available from: doi: 10.4239/wjd.v12.i9.1401. PMID: 34630897; PMCID: PMC8472500.
[9]	Saraswathi S., Al-Khawaga S., Elkum N. and Hussain K. A Systematic Review of Childhood Diabetes Research in the Middle East Region. Front [Internet]. 2019 [cited 2022 Aug 03]; 10: 805. Available from: doi: 10.3389/fendo.2019.00805.
[10]	Arab News. High Diabetes and Obesity Rates Complicate GCC’s Coronavirus Fight [Internet]. Dubai: 2020 Jun 02 [Updated 2020 Aug 12] [cited 2022 Aug 03]. Available from: https://www.arabnews.com/node/1683821/middle-east.
[11]	Huang Y., Fernandes JR., Karuranga S., Malanda B., Cho NH. Diabetes Prevalence in Middle East and Africa Region (Estimates for 2017 and 2045). International Diabetes Federation (IDF) [Internet]. 2017 [cited 2022 Aug 04]; p-0749. Available from: https://poshukach.com/redir?user_type=40&type=sr&redir=eJzLKCkpKLbS1y8vL9fLTEnTyy9K18_MS0mt0CvIKLDPLyjJzM-zTc7PjU8sKUlMzshNzSspVitJLM62Tckvz8vJT0xRy0yxNTQ1sLRyLMlJLNa1SNUtyC8uSS3S9XX1c9QtSk0HmsDAYGhmZmhoYWlhYsywp8Mz6qJdXdjtJBurZW155gBRiy6g&src=458022&via_page=1.
[12]	Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, Sadeghi A. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One [Internet]. 2011 [cited 2022 Aug 04]; 6 (10): e26864. Available from: doi: 10.1371/journal.pone.0026864. Epub 2011 Oct 31. PMID: 22066013; PMCID: PMC3204988.
[13]	Farshchi A, Esteghamati A, Sari AA, Kebriaeezadeh A, Abdollahi M, Dorkoosh FA, Khamseh ME, Aghili R, Keshtkar A, Ebadi M. The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. J Diabetes Metab Disord [Internet]. 2014 Mar 4 [cited 2022 Aug 05]; 13 (1): 42. Available from: doi: 10.1186/2251-6581-13-42. PMID: 24593991; PMCID: PMC3975900.
[14]	Systematic Reviews (OPEN ACCESS) Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews 2021; 10: 89.
[15]	Cho, N., Shaw, J., Karuranga, S., Huang, Y., da Rocha Fernandes, J., Ohlrogge, A., & Malanda, B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice [Internet]. 2018 [cited 2022 Aug 05]; 138: 271–281. Available from: https://doi.org/10.1016/j.diabres.2018.02.023.
[16]	Ansari-Moghaddam, A., Setoodehzadeh, F., Khammarnia, M., & Adineh, H. A. Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews [Internet]. 2020 [cited 2022 Aug 07]; 14 (5): 1101–1108. Available from: https://doi.org/10.1016/j.dsx.2020.06.044.
[17]	Abuyassin, B., & Laher, I. Diabetes epidemic sweeping the Arab world. World Journal of Diabetes [Internet]. 2016 [cited 2022 Aug 07]; 7 (8): 165. Available from: https://doi.org/10.4239/wjd.v7.i8.165.
[18]	Boutayeb, A., Boutayeb, W., Lamlili, M. E., & Boutayeb, S. Estimation of the direct cost of diabetes in the Arab region. Mediterranean Journal of Nutrition and Metabolism [Internet]. 2014 [cited 2022 Aug 09]; 7 (1): 21–32. Available from: https://doi.org/10.3233/mnm-140002.
[19]	Boutayeb, W. Boutayeb, M. E. N. Lamlili, S. Boutayeb. Indirect Cost Of Diabetes In The Arab Region. International Journal of Diabetology & Vascular Disease Research [Internet]. 2013 [cited 2022 Aug 10]; 2 4–28. Available from: https://doi.org/10.19070/2328-353x-130005.
[20]	The World Bank. Diabetes Prevalence [Internet]. 2022 [cited 2022 Aug 10]. Available from: https://data.worldbank.org/indicator/SH.STA.DIAB.ZS?most_recent_value_desc=true.
[21]	AlMazroa, M. Cost of Diabetes in Saudi Arabia. Iproceedings [Internet]. 2018 [cited 2022 Aug 11]; 4 (1): e10566. Available from: https://doi.org/10.2196/10566.
[22]	Mokdad, A., Tuffaha, M., Bcheraoui, C. E., & Daoud, F. Cost of diabetes in the Kingdom of Saudi Arabia, 2014. Institute for Health Metrics and Evaluation [Internet]. 2015 Sep 14 [cited 2022 Aug 11]. Available from: https://www.healthdata.org/research-article/cost-diabetes-kingdom-saudi-arabia-2014.
[23]	Naeem, Z. Burden of Diabetes Mellitus in Saudi Arabia. International Journal of Health Sciences [Internet]. 2015 [cited 2022 Aug 12]; 9 (3): V–VI. Available from: https://doi.org/10.12816/0024690.
[24]	Alhowaish, A. Economic costs of diabetes in Saudi Arabia. Journal of Family and Community Medicine [Internet]. 2013 [cited 2022 Aug 13]; 20 (1). Available from: https://doi.org/10.4103/2230-8229.108174.
[25]	Arab News. Cost of diabetes escalating [Internet]. Jeddah: 2015 Nov 27 [cited 2022 Aug 13]. Available from: https://www.arabnews.com/saudi-arabia/news/842271.
[26]	Hnoosh, A., Vega-Hernández, G., Jugrin, A., & Todorova, L. PDB45 Direct Medical Costs of Diabetes-Related Complications in Saudi Arabia. Value in Health [Internet]. 2012 [cited 2022 Aug 14]; 15 (4): A178. Available from: https://doi.org/10.1016/j.jval.2012.03.966.
[27]	Hosseini, M., Davari, M., Boroumand, Z., Amini, M., & Aslani, A. The direct medical costs of outpatient cares of Type 2 diabetes in Iran: A retrospective study. International Journal of Preventive Medicine [Internet]. 2016 [cited 2022 Aug 15]; 7 (1): 72. Available from: https://doi.org/10.4103/2008-7802.181758.
[28]	Al-Maskari, F., El-Sadig, M., & Nagelkerke, N. (2010a). Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates. BMC Public Health [Internet]. 2010 [cited 2022 Aug 15]; 10 (1). Available from: https://doi.org/10.1186/1471-2458-10-679.

Cite This Article

Plain Text BibTeX RIS

APA Style

Badr Alnasser. (2022). Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. International Journal of Health Economics and Policy, 7(3), 71-77. https://doi.org/10.11648/j.hep.20220703.15

Copy | Download

ACS Style

Badr Alnasser. Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. Int. J. Health Econ. Policy 2022, 7(3), 71-77. doi: 10.11648/j.hep.20220703.15

Copy | Download

AMA Style

Badr Alnasser. Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. Int J Health Econ Policy. 2022;7(3):71-77. doi: 10.11648/j.hep.20220703.15

Copy | Download

@article{10.11648/j.hep.20220703.15,
  author = {Badr Alnasser},
  title = {Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review},
  journal = {International Journal of Health Economics and Policy},
  volume = {7},
  number = {3},
  pages = {71-77},
  doi = {10.11648/j.hep.20220703.15},
  url = {https://doi.org/10.11648/j.hep.20220703.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hep.20220703.15},
  abstract = {Diabetic patients require expensive long-term therapy and care and the all-embracing implication of such disease negatively impacts society as a whole. Multiple indicators show that large number of diabetes mellitus-affected countries are located in the Middle East, which in some estimates reach around sixty percent of the global diabetes pandemic. It is already acknowledged that the incessant expansion of a non-transmittable illness in this region forces huge monetary expenses on families and nations. This systematic review analyzed the literature on the economic cost of diabetes in the Middle East and yielded 13 studies focusing on this issue. Results show that Middle-Eastern countries bare substantial economic cost, directly and indirectly, for treating and managing its diabetes population. From those nations, the Arabic-speaking countries share a higher portion of diabetes cost compared to other countries. While the Gulf states comprised the highest proportion of such cost. Although studies have been conducted on the cost of diabetes mellitus in the Middle East, yet very little has had significant impact on the awareness of the economic problem associated with it. The focus of this study shall be to encapsulate existing evidence on the expense of diabetes mellitus in the Middle East, survey the strategies used to work out costs, and explore regions for future implication.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review
AU  - Badr Alnasser
Y1  - 2022/09/16
PY  - 2022
N1  - https://doi.org/10.11648/j.hep.20220703.15
DO  - 10.11648/j.hep.20220703.15
T2  - International Journal of Health Economics and Policy
JF  - International Journal of Health Economics and Policy
JO  - International Journal of Health Economics and Policy
SP  - 71
EP  - 77
PB  - Science Publishing Group
SN  - 2578-9309
UR  - https://doi.org/10.11648/j.hep.20220703.15
AB  - Diabetic patients require expensive long-term therapy and care and the all-embracing implication of such disease negatively impacts society as a whole. Multiple indicators show that large number of diabetes mellitus-affected countries are located in the Middle East, which in some estimates reach around sixty percent of the global diabetes pandemic. It is already acknowledged that the incessant expansion of a non-transmittable illness in this region forces huge monetary expenses on families and nations. This systematic review analyzed the literature on the economic cost of diabetes in the Middle East and yielded 13 studies focusing on this issue. Results show that Middle-Eastern countries bare substantial economic cost, directly and indirectly, for treating and managing its diabetes population. From those nations, the Arabic-speaking countries share a higher portion of diabetes cost compared to other countries. While the Gulf states comprised the highest proportion of such cost. Although studies have been conducted on the cost of diabetes mellitus in the Middle East, yet very little has had significant impact on the awareness of the economic problem associated with it. The focus of this study shall be to encapsulate existing evidence on the expense of diabetes mellitus in the Middle East, survey the strategies used to work out costs, and explore regions for future implication.
VL  - 7
IS  - 3
ER  -

Copy | Download

Author Information

Badr Alnasser

Department of Health Management, College of Public Health and Health Informatics, University of Ha’il, Hail, Saudi Arabia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Badr Alnasser. (2022). Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. International Journal of Health Economics and Policy, 7(3), 71-77. https://doi.org/10.11648/j.hep.20220703.15

Copy | Download

ACS Style

Badr Alnasser. Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. Int. J. Health Econ. Policy 2022, 7(3), 71-77. doi: 10.11648/j.hep.20220703.15

Copy | Download

AMA Style

Badr Alnasser. Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review. Int J Health Econ Policy. 2022;7(3):71-77. doi: 10.11648/j.hep.20220703.15

Copy | Download

@article{10.11648/j.hep.20220703.15,
  author = {Badr Alnasser},
  title = {Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review},
  journal = {International Journal of Health Economics and Policy},
  volume = {7},
  number = {3},
  pages = {71-77},
  doi = {10.11648/j.hep.20220703.15},
  url = {https://doi.org/10.11648/j.hep.20220703.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.hep.20220703.15},
  abstract = {Diabetic patients require expensive long-term therapy and care and the all-embracing implication of such disease negatively impacts society as a whole. Multiple indicators show that large number of diabetes mellitus-affected countries are located in the Middle East, which in some estimates reach around sixty percent of the global diabetes pandemic. It is already acknowledged that the incessant expansion of a non-transmittable illness in this region forces huge monetary expenses on families and nations. This systematic review analyzed the literature on the economic cost of diabetes in the Middle East and yielded 13 studies focusing on this issue. Results show that Middle-Eastern countries bare substantial economic cost, directly and indirectly, for treating and managing its diabetes population. From those nations, the Arabic-speaking countries share a higher portion of diabetes cost compared to other countries. While the Gulf states comprised the highest proportion of such cost. Although studies have been conducted on the cost of diabetes mellitus in the Middle East, yet very little has had significant impact on the awareness of the economic problem associated with it. The focus of this study shall be to encapsulate existing evidence on the expense of diabetes mellitus in the Middle East, survey the strategies used to work out costs, and explore regions for future implication.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Economic Cost of Diabetes Mellitus in the Middle East: A Systematic Review
AU  - Badr Alnasser
Y1  - 2022/09/16
PY  - 2022
N1  - https://doi.org/10.11648/j.hep.20220703.15
DO  - 10.11648/j.hep.20220703.15
T2  - International Journal of Health Economics and Policy
JF  - International Journal of Health Economics and Policy
JO  - International Journal of Health Economics and Policy
SP  - 71
EP  - 77
PB  - Science Publishing Group
SN  - 2578-9309
UR  - https://doi.org/10.11648/j.hep.20220703.15
AB  - Diabetic patients require expensive long-term therapy and care and the all-embracing implication of such disease negatively impacts society as a whole. Multiple indicators show that large number of diabetes mellitus-affected countries are located in the Middle East, which in some estimates reach around sixty percent of the global diabetes pandemic. It is already acknowledged that the incessant expansion of a non-transmittable illness in this region forces huge monetary expenses on families and nations. This systematic review analyzed the literature on the economic cost of diabetes in the Middle East and yielded 13 studies focusing on this issue. Results show that Middle-Eastern countries bare substantial economic cost, directly and indirectly, for treating and managing its diabetes population. From those nations, the Arabic-speaking countries share a higher portion of diabetes cost compared to other countries. While the Gulf states comprised the highest proportion of such cost. Although studies have been conducted on the cost of diabetes mellitus in the Middle East, yet very little has had significant impact on the awareness of the economic problem associated with it. The focus of this study shall be to encapsulate existing evidence on the expense of diabetes mellitus in the Middle East, survey the strategies used to work out costs, and explore regions for future implication.
VL  - 7
IS  - 3
ER  -

Copy | Download